Myotonic dystrophy
Information
- Disease name
- Myotonic dystrophy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05479981 | Active, not recruiting | Phase 2 | Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients | August 4, 2022 | June 2025 |
| NCT04616807 | Active, not recruiting | An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders | December 17, 2020 | January 24, 2026 | |
| NCT01136330 | Completed | DM1 Heart Registry - DM1 Respiratory Registry | May 2010 | September 2011 | |
| NCT01242007 | Completed | N/A | Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients | April 2008 | June 2010 |
| NCT05027269 | Completed | Phase 1/Phase 2 | Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients | October 28, 2021 | February 14, 2023 |
| NCT01406873 | Completed | Phase 2 | Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 | June 2011 | March 2017 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT02375087 | Completed | Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ? | May 20, 2014 | July 1, 2017 | |
| NCT03959189 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1 | June 17, 2019 | April 30, 2020 |
| NCT00233519 | Completed | Phase 1/Phase 2 | Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1) | November 2005 | May 2008 |
| NCT00167609 | Completed | Phase 2/Phase 3 | Efficacy and Safety of DHEA for Myotonic Dystrophy | November 2004 | December 2006 |
| NCT06147414 | Not yet recruiting | Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders | April 2024 | December 2026 | |
| NCT06411288 | Recruiting | Phase 3 | Global Study of Del-desiran for the Treatment of DM1 | May 30, 2024 | April 2027 |
| NCT02398786 | Recruiting | Myotonic Dystrophy Family Registry | February 2013 | February 2025 | |
| NCT04003363 | Recruiting | The United Kingdom National Registry for Myotonic Dystrophy | May 2013 | December 2030 | |
| NCT04624750 | Recruiting | Phase 3 | Open Label Study in Adolescents and Children With Myotonic Disorders | September 3, 2021 | August 8, 2024 |
| NCT05019625 | Recruiting | Biomarker Development for Muscular Dystrophies | February 20, 2015 | June 2027 | |
| NCT05020002 | Recruiting | Extracellular RNA Biomarkers of Myotonic Dystrophy | December 8, 2020 | December 2025 | |
| NCT05890833 | Recruiting | The Risk of Falls Index for Patients With Neuromuscular Disorders | September 1, 2023 | September 1, 2025 | |
| NCT00082108 | Recruiting | Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry | September 2000 | June 2024 | |
| NCT02315339 | Terminated | European Home Mechanical Ventilation Registry | August 2014 | January 2019 | |
| NCT00127582 | Unknown status | Phase 3 | RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy | January 2003 |
- OMIM Phenotype Series Number (OMIM)
- PS160900
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009223